Zydus Lifesciences Limited — Others, 09-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Zydus Lifesciences has announced a board meeting to discuss the financial results for the quarter and half-year. For the quarter ended March 31, 2025, the company has confirmed that equity shares received for dematerialization were properly processed, with certificates mutilated and cancelled after verification. All dematerialized shares are listed on both BSE and NSE. This update reflects effective compliance with procedural norms in share handling, enhancing shareholder transparency. Investors may view this as a sign of operational efficiency, contributing to a positive outlook amidst ongoing corporate governance efforts.